Office of Environmental Health Hazard Assessment

Most Popular Links

Listservs

More Resources

Prop. 65 resources

Enforcement

Administrative Listing Mechanism

State’s Qualified Experts Mechanism

More Resources

 

Proposition 65

Notice of Intent to List a Chemical by the "Formally Required to be Labeled or Identified" Mechanism: Clomiphene Citrate
[04/05/13]

Comment period closed on May 6, 2013.  No comments received.

The California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) intends to list the chemical identified in the table below as known to the State to cause cancer under the Safe Drinking Water and Toxic Enforcement Act of 1986.1 This action is being proposed under the “formally required to be labeled or identified” listing mechanism.2

Chemical

CAS No.

Endpoint

Reference

Clomiphene citrate

911-45-5

Cancer

FDA (2012)

Background on listing via the formally required to be labeled or identified mechanism: A chemical must be listed under the Proposition 65 regulations (Section 259023) when a state or federal agency has formally required it to be labeled or identified as causing cancer or reproductive toxicity.
According to Section 25902(b):

OEHHA is the lead agency for Proposition 65 implementation. After a state or federal agency has required that a chemical be labeled or identified as causing cancer or reproductive toxicity, OEHHA evaluates whether listing under Proposition 65 is required pursuant to the definitions set out in Section 25902.

OEHHA’s determination: Clomiphene citrate has been identified or labeled to communicate a risk of cancer in accordance with formal requirements by the U.S. Food and Drug Administration (FDA).

Language from the FDA-approved product label which meets the requirements of Section 25902 is quoted below:

clomiphene citrate

Cancer Endpoint (Under PRECAUTIONS and Adverse Reactions)
Under PRECAUTIONS: “Prolonged use of clomiphene citrate tablets USP may increase the risk of borderline or invasive ovarian tumor (see ADVERSE REACTIONS).”
Under ADVERSE REACTIONS: “Ovarian cancer has been infrequently reported in patients who have received fertility drugs. Infertility is a primary risk factor for ovarian cancer; however, epidemiology data suggest that prolonged use of clomiphene may increase the risk of a borderline or invasive ovarian tumor.”

Request for comments: OEHHA is requesting comments as to whether this chemical meets the criteria set forth in the Proposition 65 regulations for listings via the formally required to be labeled or identified mechanism (Section 25902). Because these are ministerial listings, comments should be limited to whether FDA requires that clomiphene citrate be labeled to communicate a risk of cancer or tumors. OEHHA cannot consider scientific arguments concerning the weight or quality of the evidence considered by FDA when it established the labeling requirement and will not respond to such comments if they are submitted. In order to be considered, OEHHA must receive comments by 5:00 p.m. on MONDAY, May 6, 2013. We encourage you to submit comments in electronic form, rather than in paper form. Comments transmitted by e-mail should be addressed to P65Public.Comments@oehha.ca.gov with “NOIL-Clomiphene citrate” in the subject line. Comments submitted in paper form may be mailed, faxed, or delivered in person to the address below:

Mailing Address: Ms. Cynthia Oshita
Office of Environmental Health Hazard Assessment
P.O. Box 4010, MS-19B
Sacramento, California 95812-4010
Fax: (916) 323-2265
Street Address: 1001 I Street
Sacramento, California 95814

Comments received during the public comment period will be posted on the OEHHA web site after the close of the comment period.

If you have any questions, please contact Ms. Oshita at cynthia.oshita@oehha.ca.gov or at (916) 445-6900.

Reference
Food and Drug Administration (FDA, 2012). FDA approved labeling for the drug clomiphene citrate. Approved by FDA in October 2012 and found at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#labelinfo

1 Commonly known as Proposition 65, the Safe Drinking Water and Toxic Enforcement Act of 1986 is codified in Health and Safety Code section 25249.5 et seq.

2 See Health and Safety Code section 25249.8(b) and Title 27, Cal. Code of Regs., section 25902.

3 All referenced sections are from Title 27 of the Cal. Code of Regulations.

 
 
Flex Your Power Website
Energy efficiency and conservation information. Find incentives/rebates, technical assistance, retailers, product guides, case studies and more.
AMBER ALERT: Save a Child Amber Alert logo
AMBER ALERT empowers law enforcement, the media and the public to combat abduction by sending out immediate information.